UnitedHealth Group Incorporated [NYSE: UNH] stock went on a downward path that fall over -0.14% on Wednesday, amounting to a one-week price decrease of less than -4.30%. Over the last 12 months, UNH stock rose by 19.09%. The one-year UnitedHealth Group Incorporated stock forecast points to a potential upside of 11.55. The average equity rating for UNH stock is currently 1.80, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $276.11 billion, with 949.00 million shares outstanding and 941.91 million shares in the current float. Compared to the average trading volume of 5.24M shares, UNH stock reached a trading volume of 2536881 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Guru’s Opinion on UnitedHealth Group Incorporated [UNH]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for UNH shares is $330.79 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on UNH stock is a recommendation set at 1.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Goldman have made an estimate for UnitedHealth Group Incorporated shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 05, 2020. The new note on the price target was released on March 20, 2020, representing the official price target for UnitedHealth Group Incorporated stock. Previously, the target price had yet another raise to $270, while Mizuho analysts kept a Buy rating on UNH stock. On October 10, 2019, analysts decreased their price target for UNH shares from 300 to 235.
The Average True Range (ATR) for UnitedHealth Group Incorporated is set at 9.66, with the Price to Sales ratio for UNH stock in the period of the last 12 months amounting to 1.12. The Price to Book ratio for the last quarter was 4.87, with the Price to Cash per share for the same quarter was set at 22.86. Price to Free Cash Flow for UNH in the course of the last twelve months was 22.82.
UNH Stock Performance Analysis:
UnitedHealth Group Incorporated [UNH] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -4.30. With this latest performance, UNH shares dropped by -0.26% in over the last four-week period, additionally plugging by 0.20% over the last 6 months – not to mention a rise of 19.09% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for UNH stock in for the last two-week period is set at 48.24, with the RSI for the last a single of trading hit 45.72, and the three-weeks RSI is set at 50.75 for UnitedHealth Group Incorporated [UNH]. The present Moving Average for the last 50 days of trading for this stock 289.33, while it was recorded at 288.15 for the last single week of trading, and 268.96 for the last 200 days.
Insight into UnitedHealth Group Incorporated Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and UnitedHealth Group Incorporated [UNH] shares currently have an operating margin of +8.13. UnitedHealth Group Incorporated’s Net Margin is presently recorded at +5.71.
Return on Total Capital for UNH is now 20.13, given the latest momentum, and Return on Invested Capital for the company is 15.32. Return on Equity for this stock inclined to 25.32, with Return on Assets sitting at 8.36. When it comes to the capital structure of this company, UnitedHealth Group Incorporated [UNH] has a Total Debt to Total Equity ratio set at 70.60. Additionally, UNH Total Debt to Total Capital is recorded at 41.38, with Total Debt to Total Assets ending up at 23.01. Long-Term Debt to Equity for the company is recorded at 63.89, with the Long-Term Debt to Total Capital now at 37.45.
Reflecting on the efficiency of the workforce at the company, UnitedHealth Group Incorporated [UNH] managed to generate an average of $42,582 per employee.
UNH Stock EPS
With the latest financial reports released by the company, UnitedHealth Group Incorporated posted 3.6/share EPS, while the average EPS was predicted by analysts to be reported at 3.45/share.When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 4.30%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for UNH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for UnitedHealth Group Incorporated go to 12.72%.
UnitedHealth Group Incorporated [UNH] Insider Position Details
There are presently around $244,869 million, or 89.60% of UNH stock, in the hands of institutional investors. The top three institutional holders of UNH stocks are: VANGUARD GROUP INC with ownership of 75,072,946, which is approximately 2.625% of the company’s market cap and around 0.30% of the total institutional ownership; BLACKROCK INC., holding 69,749,300 shares of the stock with an approximate value of $20.44 billion in UNH stocks shares; and FMR LLC, currently with $16.2 billion in UNH stock with ownership of nearly -2.312% of the company’s market capitalization.
Positions in UnitedHealth Group Incorporated stocks held by institutional investors increased at the end of April and at the time of the April reporting period, where 1,061 institutional holders increased their position in UnitedHealth Group Incorporated [NYSE:UNH] by around 40,668,617 shares. Additionally, 1,062 investors decreased positions by around 43,599,261 shares, while 185 investors held positions by with 751,462,104 shares. The mentioned changes placed institutional holdings at 835,729,982 shares, according to the latest SEC report filing. UNH stock had 157 new institutional investments in for a total of 4,934,000 shares, while 161 institutional investors sold positions of 3,484,129 shares during the same period.